COVID-19 mortality in patients on anticoagulants and antiplatelet agents.

Sivaloganathan, Helena; Ladikou, Eleni E; Chevassut, Timothy

Sivaloganathan, Helena; Ladikou, Eleni E; Chevassut, Timothy.

Sivaloganathan H; Brighton and Sussex Medical School, University of Sussex, Brighton, UK.
Ladikou EE; Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Chevassut T; Brighton and Sussex Medical School, University of Sussex, Brighton, UK.

Br J Haematol ; 190(4): e192-e195, 2020 08.

Article in English | MEDLINE | ID: covidwho-614298

Subject(s)

Anticoagulants/administration & dosage; COVID-19 Drug Treatment; COVID-19/mortality; Hospital Mortality; Platelet Aggregation Inhibitors/administration & dosage; SARS-CoV-2; Aged; Aged, 80 and over; COVID-19/blood; Disease-Free Survival; Female; Humans; Male; Survival Rate

Keywords

COVID-19; anticoagulants; antiplatelets; mortality; thrombosis; thrombosis (venous)

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Platelet Aggregation Inhibitors / Hospital Mortality / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment / Anticoagulants Type of study: Prognostic study / Randomized controlled trials Limits: Aged / Female / Humans / Male Language: English Journal: Br J Haematol Year: 2020 Document Type: Article Affiliation country: Bjh.16968

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google